Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Addiction. 2020 Jan 20;115(5):924–932. doi: 10.1111/add.14886

Table 1:

Characteristics of the sample of individuals who received buprenorphine in Massachusetts between 2012–2015

Receipt of benzodiazepine at any time while also prescribed buprenorphine* Total
Characteristic No (n=48,062)
n (%)
Yes (n=15,283)
n (%)
n=63,345
n (%)
Female 16,343 (34) 7,435 (49) 23,778 (38)
Age, mean (SD) 37 (11) 40 (11) 38 (11)
Medicaid enrollment 21,172 (44) 6,666 (44) 27,838 (44)
Anxiety disorder 8,479 (18) 5,493 (36) 13,972 (22)
Depressive disorder 11,090 (23) 6,045 (40) 17,135 (27)
Bipolar/psychotic disorder 2,849 (6) 1,690 (11) 4,539 (7)
Receipt of SSRI prescription 3,178 (7) 1,865 (12) 5,043 (8)
Hospital-based mental health-related encounter** 17,015 (35) 6,238 (41) 23,253 (37)
*

p<0.001 for all comparisons between groups except for Medicaid enrollment which had p-value of 0.45.

**

Emergency department, observation, or inpatient discharge for mental health condition